Evidence map›Paper›PMID 38816609›Full record

Observational studyNature medicine2024

Multimodal assessment improves neuroprognosis performance in clinically unresponsive critical-care patients with brain injury.

B Rohaut, C Calligaris, B Hermann, P Perez, F Faugeras, F Raimondo, J-R King, D Engemann, C Marois, L Le Guennec and 19 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04534777 (Multimodal Neuroprognostication in Disorders of Consciousness), which is not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04534777 recruitingnot on this map

Multimodal Neuroprognostication in Disorders of Consciousness

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2020 to 2027Enrolled500ConditionsConsciousness DisorderArmsrepeated neurological, behavioral assessments and conventional, quantitative and functional brain imagery
3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

B Rohaut *Sorbonne Université, Paris, France. benjamin.rohaut@sorbonne-universite.fr.ORCID 0000-0001-6752-8756
C Calligaris *APHP, Hôpital de la Pitié Salpêtrière, DMU Neurosciences - Neuro ICU, Paris, France.
B HermannParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.ORCID 0000-0001-9071-3415
P PerezParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.ORCID 0000-0001-6812-1376
F FaugerasParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.
F RaimondoParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.ORCID 0000-0003-4087-8259
J-R KingParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.ORCID 0000-0002-2121-170X
D EngemannParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.ORCID 0000-0002-7223-1014
C MaroisParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.
L Le GuennecSorbonne Université, Paris, France.ORCID 0000-0001-8146-6256
L Di MeglioSorbonne Université, Paris, France.ORCID 0000-0002-5158-8612
A SangaréSorbonne Université, Paris, France.
E Munoz MusatParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.ORCID 0000-0002-3477-3429
M ValenteParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.
A Ben SalahSorbonne Université, Paris, France.
A DemertziParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.ORCID 0000-0001-8021-3759
L BelloliParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.ORCID 0000-0002-4093-7135
D ManasovaParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.ORCID 0000-0002-2756-3263
L JodaitisParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.
M O HabertSorbonne Université, Paris, France.ORCID 0000-0002-7719-9746
V LambrecqSorbonne Université, Paris, France.ORCID 0000-0001-9442-0302
N PyatigorskayaSorbonne Université, Paris, France.
D GalanaudSorbonne Université, Paris, France.
L PuybassetSorbonne Université, Paris, France.
N WeissSorbonne Université, Paris, France.ORCID 0000-0001-5155-196X
S DemeretAPHP, Hôpital de la Pitié Salpêtrière, DMU Neurosciences - Neuro ICU, Paris, France.
F X LejeuneParis Brain Institute - ICM, Inserm, CNRS, Data Analysis Core, Paris, France.ORCID 0000-0002-6229-5364
J D SittParis Brain Institute - ICM, Inserm, CNRS, PICNIC-Lab, Paris, France.ORCID 0000-0002-3878-4846
L Naccache *Sorbonne Université, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurately predicting functional outcomes for unresponsive patients with acute brain injury is a medical, scientific and ethical challenge. This prospective study assesses how a multimodal approach combining various numbers of behavioral, neuroimaging and electrophysiological markers affects the performance of outcome predictions. We analyzed data from 349 patients admitted to a tertiary neurointensive care unit between 2009 and 2021, categorizing prognoses as good, uncertain or poor, and compared these predictions with observed outcomes using the Glasgow Outcome Scale-Extended (GOS-E, levels ranging from 1 to 8, with higher levels indicating better outcomes). After excluding cases with life-sustaining therapy withdrawal to mitigate the self-fulfilling prophecy bias, our findings reveal that a good prognosis, compared with a poor or uncertain one, is associated with better one-year functional outcomes (common odds ratio (95% CI) for higher GOS-E: OR = 14.57 (5.70-40.32), P < 0.001; and 2.9 (1.56-5.45), P < 0.001, respectively). Moreover, increasing the number of assessment modalities decreased uncertainty (OR = 0.35 (0.21-0.59), P < 0.001) and improved prognostic accuracy (OR = 2.72 (1.18-6.47), P = 0.011). Our results underscore the value of multimodal assessment in refining neuroprognostic precision, thereby offering a robust foundation for clinical decision-making processes for acutely brain-injured patients. ClinicalTrials.gov registration: NCT04534777 .

Indexed as

Brain InjuriesCritical CareAdultAgedFemaleGlasgow Outcome ScaleHumansMaleMiddle AgedNeuroimagingPrognosisProspective Studies

Identifiers

PMID38816609
PMCPMC11333287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.